TrialPloS one2023

Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.

Claudia E Frola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.